SP
GILD icon

Stonebrook Private’s Gilead Sciences GILD Stock Holding History

Stonebrook Private’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278K Buy
2,201
+13
+0.6% +$1.71K 0.05% 200
2026
Q1 		$305K Buy
2,188
+48
+2% +$6.72K 0.06% 164
2025
Q4 		$263K Buy
2,140
+167
+8% +$20.3K 0.06% 172
2025
Q3 		$219K Buy
+1,973
New +$224K 0.05% 191

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stonebrook Private's GILD Position: Q2 2026 in Review

Stonebrook Private increased its Gilead Sciences (GILD) stake by 0.59% in Q2 2026, buying an estimated $1.71K and bringing the position to 2,201 shares worth $278K. The position accounts for 0.05% of the portfolio, ranked #200.

Stonebrook Private first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $305K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Stonebrook Private held 2,201 shares of Gilead Sciences worth $278K as of Q2 2026.
  • Stonebrook Private bought 13 Gilead Sciences shares in Q2 2026, an estimated $1.71K.
  • Gilead Sciences made up 0.05% of Stonebrook Private's portfolio in Q2 2026, its #200 holding.
  • Stonebrook Private first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • Stonebrook Private's Gilead Sciences position peaked at $305K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Stonebrook Private's 13F filing for Q2 2026, filed 14 Aug 2026.